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Abstract The enzyme arylalkylamine N-acetyltransferase 
(aaNAT) catalyzes the rate-limiting step in melatonin formation 
in the vertebrate pineal gland. Numerous attempts to purify this 
highly unstable enzyme from vertebrates have been unsuccessful. 
Here, we report the purification of an aaNAT enzyme from 
Drosophila melanogaster, using a radioenzymatic activity assay 
and column chromatography. The isolated 29.5-kDa protein ace- 
tylates tryptamine, dopamine and serotonin with affinities of 0.89 
to 0.97 mM, respectively. This suggests that the identified 
aaNAT may be involved in melatonin synthesis and sclerotization 
as well as in neurotransmitter catabolism in insects. 
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1. Introduction 
In the vertebrate pineal gland, an acetyl-CoA-dependent 
arylalkylamine N-acetyltransferase (aaNAT, EC 2.3.1.87) cata- 
lyzes the rate-limiting step, the acetylation of serotonin, in the 
production of melatonin. Melatonin is secreted periodically, 
resulting in high concentrations atnight, translating photoperi- 
odic information via the nervous system into hormonal signals 
which regulate several physiological processes [1,2]. The cir- 
cadian rhythm of melatonin production was shown to result 
from a 10- to 100-fold nocturnal increase in aaNAT activity [3]. 
The enzyme is hormonally controlled by an endogenous clock 
located in the hypothalamic suprachiasmatic nucleus (SCN) [4]. 
At night, the SCN induces the secretion of norepinephrine 
which acts on the pineal gland through a complex mechanism, 
involving the production of cAMP as well as Ca 2+ as second 
messengers [3]. The final steps of aaNAT activation, as well as 
the rapid decrease in enzyme activity upon light exposure dur- 
ing or at the end of the dark period, need further studies. Due 
to the high instability of aaNAT in vertebrates, purification and 
cloning were unsuccessful so far, preventing studies of aaNAT 
regulation at the molecular level. Since all organisms are influ- 
enced by environmental factors, such as light and darkness, 
they need a mechanism to coordinate their physiological proc- 
esses in response to seasonal changes. In various invertebrate 
species, serotonin, aaNAT activity and melatonin have indeed 
been found in several organs, including eyes, optic lobe and 
brain [5-11], supporting the idea that melatonin is an evolution- 
ary highly conserved endogenous mediator of photoperiodic 
information [5]. In insects, besides melatonin formation (stud- 
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ied e.g. in Drosophila melanogaster by Finocchiario et al. [12]), 
aaNAT plays important roles in the sclerotization of the insect 
cuticle [13] and the catabolism of neurotransmitters [14-17]. In 
the present study, we have purified aaNAT from D. melanogas- 
ter, using tryptamine acetylation as functional enzyme assay. 
This invertebrate nzyme will hopefully provide the informa- 
tion to identify the corresponding aaNAT in vertebrates. 
2. Materials and methods 
2.1. Assay for aaNAT activity 
A modification of the assay described by Deguchi and Axelrod was 
used [18]. 50 ¢tl of a diluted protein preparation were mixed with 25/tl 
tryptamine (Sigma, Germany), 40 mM, in TEN buffer (50 mM Tris- 
HC1 pH 7.2, 1 mM EDTA, 50 mM NaC1) and 25/11 [1J4C]acetyl-CoA 
(Amersham International, Amersham, UK), 2 mM (specific activ- 
ity -- 0.6 mCi/mmol), in TEN buffer and incubated at 37°C. After 20 
min, the incubation was stopped by the addition of I ml water-saturated 
chloroform. The tubes were vortexed (30 s) and centrifuged (12,000 x g, 
1 min). The aqueous layer was aspirated and the chloroform extract 
containing the acety|ated substrate was washed twice with 200 pl 1 N 
NaOH. A 500 ,ul sample of the organic phase was transferred to a 
scintillation vial and evaporated at 40°C under a stream of nitrogen. 
5 ml scintillation cocktail (Emulsifier-Safe, Packard, The Netherlands) 
were added and radioactivity was determined. If serotonin or dopamine 
were used as substrate (both Sigma), 40 mM, in TEN buffer, 1 ml 
isoamylalcohol r toluol/isoamylalcohol (3 : 2) was added, respectively, 
to extract he acetylated product [19]. The tubes were vortexed and 
centrifuged as described above and 500 pl of the organic supernatant 
were transferred to a scintillation vial and directly mixed with 5 ml 
scintillation cocktail. 
2.2. Maintenance offly cultures 
The Oregon-R wild-type strain of D. melanogaster was maintained 
at 25°C on standard cornmeal agar medium and live yeast, acclimatized 
to a L12:D12 photoperiod (12 h light, 12 h dark). Adult flies (1-2 days 
old) were cold-shocked at 4°C, harvested and stored at -70°C until 
further use. 
2.3. Enzyme purification 
Flies were ground in a mortar at a concentration of 1 g/3 ml in 
ice-cold TEND buffer (TEN buffer with 2 mM DTT (dithiothreitol)), 
containing 10% glycerol, 0.1 mM PMSF (phenyl-methyl-sulfonyl- 
ftuorid), 0.02 mM BHT (butylated hydroxylated toluene), 0.01 mM 
pepstatin and 0.1 mM trypsin inhibitor. The homogenate was centri- 
fuged at 4°C for 30 min at 10,000 x g. The supernatant was filtered 
through Miracloth (Calbiochem, San Diego, CA) and recentrifuged. A 
100-ml aliquot of this supernatant fraction was brought o 15% satura- 
tion with a stock solution of 60% PEG (polyethyleneglycol) 8000 in 
TEN. After 1 h incubation at 4°C on a magnetic stirrer, the sample was 
centrifuged for 30 min at 10,000 × g. The supernatant was diluted 1 : 5 
with TEND buffer for application to a column (4.5 cm x 5 cm) of 
DEAE-Sepharose (Pharmacia, Uppsala, Sweden), equilibrated with 3% 
PEG 8000 in TEN at a flow rate of 8.5 ml/min. After stepwise washing 
with 7 column volumes ofTEN and 4 column volumes ofTEN contain- 
ing 80 mM NaC1, enzyme activity was eluted with TEND containing 
170 mM NaCI (total volume 160 ml). The active pool was concentrated 
to 2 ml by ultrafiltration through a centriprepl0 membrane (Amicon, 
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Grace company, Beverly, MA). The sample was loaded onto a Se- 
phacryl S-200 (Pharmacia) column (1.5 cmx 80 cm) which was devel- 
oped at 10 ml/h with 5 mM sodium phosphate buffer (pH 6.8) contain- 
ing 2 mM DTT. Active fractions (2 ml) were pooled and applied to a 
Bio-Gel HTP Hydroxylapatite (BioRad, Richmond, CA) column (1.5 
cm x 4.5 cm) at a flow rate of 35 ml/h. The column was washed with 
20 ml 5 mM sodium phosphate (pH 6.8), collecting 4-ml fractions. 
Proteins were eluted with a linear gradient (100 ml) from 5 to 50 mM 
phosphate in the same buffer and in addition a final wash was per- 
formed with 20 ml 55 mM phosphate buffer. The pool of active frac- 
tions (54 ml) was brought o a 1.7 M ammonium sulfate concentration 
by adding solid ammonium sulfate. The sample was loaded on a Butyl- 
Sepharose (Pharmacia) column (1.5 cm × 1.5 cm), equilibrated with 1.7 
M ammonium sulfate in 50 mM sodium phosphate buffer (pH 6.8) at 
a flow rate of 10 ml/h. After washing with 12 ml equilibration buffer, 
the proteins were eluted with 20 ml 1.3 M ammonium sulfate in 50 mM 
phosphate buffer (pH 6.8), collecting l-ml fractions. Fractions 7-18 
were pooled and TCA (trichloracetic a id) precipitated. The pellet was 
stored at -70°C. 
Protein content was determined with a dye-binding assay, using bo- 
vine serum albumin as standard [20]. 
2.4. Internal peptide sequence determination 
The collected TCA pellets of aaNAT were subjected to two-dimen- 
sional gel electrophoresis as described by O'Farell [21]. The TCA pellets 
were resuspended in sample buffer containing 2.0% nonidet P40 and 
focused using a pH gradient from pH 3.0 to pH 10 (1.6% 517 ampholyte 
and 0.4% 3110 ampholyte; BioRad). The second dimension was SDS- 
PAGE with a 15% polyacrylamide gel which was Coomassie blue- 
stained for protein detection. The protein spot containing aaNAT was 
digested in the gel piece with endoproteinase LysC (Wako Chemicals, 
Neuss, Germany). Peptide fragments were separated by reverse-phase 
HPLC and selected fractions were subjected to automated Edman deg- 
radation as described in [22]. 
2.5. Determination of pI and M r 
The isoelectric point (pI) was determined with a pI marker kit (Bio- 
Rad) under the same conditions as used before protease digest of 
aaNAT in the gel piece (see above). Mr was estimated by SDS-PAGE, 
using appropriate low molecular weight standard proteins (BioRad). 
2.6. Kinetic studies 
Velocities of amine acetylation were determined by keeping the con- 
centration of [1J4C]acetyl-CoA at 2 mM and varying substrate concen- 
trations from 0.1 to 16 mM for tryptamine, from 0.02 to 2 mM for 
serotonin and from 0.005 to 4 mM for dopamine. Km was determined 
by the data analysis program Grafit [23]. 
3. Results and discussion 
Since the vertebrate aaNAT is highly unstable during purifi- 
cation and distinct from already characterized N-acetyltrans- 
ferases [24], protein isolation or homology-based cloning of 
aaNAT were without success so far. The assumptions that an 
evolutionary highly conserved molecule, like melatonin, is 
formed by an evenly conserved biosynthetic pathway and that 
the enzyme might be more stable in a simpler organism led us 
to isolate and characterize aaNAT from an invertebrate spe- 
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Purification of arylalkylamine N-acetyltransferase from D. melanogaster 
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Fig. 1. Identification of aaNAT protein after hydrophobic interaction 
chromatography. After Butyl-Sepharose chromatography, eluted frac- 
tions were analysed for protein content on a silver stained 15% 
acrylamide gel (A) and for aaNAT enzyme activity. (B) The relative 
band intensities were determined by densitometry: Scanl = relative in- 
tensity of the marked lower band (arrow head); scan2 = relative inten- 
sity of the major contaminating band. Band intensities were compared 
with the measured enzyme activity (curve, in cpm). 
cies. aaNAT activity in D. melanogaster was indeed relatively 
stable; enzyme activity in a sample of the first chromatographic 
step (DEAE-Sepharose) was only slightly reduced to 84% of the 
initial activity when incubated for 3 days at 4°C. Thus, using 
tryptamine acetylation as functional enzyme assay, the purifica- 
t ion of a protein fraction with high arylalkylamine N-ace- 
tyltransferase activity to apparent electrophoretic homogeneity 
was achieved. The described isolation procedure resulted in a 
490-fold purification with a recovery of 7.4% (Table 1). A 15% 
polyethyleneglycol precipitation was followed by classical col- 
umn chromatography. The last chromatography step, hydro- 
phobic interaction chromatography on a Butyl-Sepharose col- 
umn, led to a protein elution pattern with one single band 
whose staining intensity correlated with the enzyme activity 
measured in the corresponding fractions (Fig. 1). The isolated 
enzyme showed an apparent molecular mass of 29.5 + 0.1 kDa 
as estimated by SDS-PAGE (n = 3, values = mean + S.D.). 
Step Protein (mg) Total activity Spec. activity Purification (fold) Recovery 
(ktmol/h) (/2mol/mg x h) (% of total activity) 
10,000 × g supernatant 560 1974 3.5 - - 
PEG supernatant 91.8 1244 13.5 3.8 63 
DEAE-Sepharose 4 827 206.5 58.6 42 
Centriprep 3 789.5 268.5 76.2 40 
Sephacryl S-200 1.5 522 348 98.7 26.5 
Hydroxylapatite 0.38 384 1010 288.5 19.5 
Butyl-Sepharose 0.085 146 1715 490 7.4 
150 
Table 2 
Affinities of aaNAT for different substrates after Hydroxylapatite 
chromatography 
Substrate Michaelis-Menten constant (Km (mean + S.D.)) 
Tryptamine 0.89 + 0.04 mM (n = 5) 
Serotonin 0.91 + 0.39 mM (n = 4) 
Dopamine 0.97 + 0.30 mM (n = 4) 
This value corresponds to studies by Maranda and Hodgetts 
[25], who determined native aaNAT of D. melanogaster as a 
29-kDa enzyme, indicating that aaNAT probably is a mono- 
mer. Using a pI marker kit, the isoelectric point was determined 
as 5.52 + 0.02 (n = 4, values = mean + S.D.). To reach a high 
purity of the isolated protein, the pool of active fractions after 
hydrophobic nteracion chromatography was subjected to two- 
dimensional gel electrophoresis prior to further analysis of 
aaNAT by internal sequence determination. Assuming a mean 
molecular mass of 29 kDa, 16% of the total amino acid se- 
quence could be determined (Table 2) by automated N-terminal 
sequencing. The peptides howed neither evident homology to 
other N-acetyltransferases norto D. melanogaster proteins in 
a SWlSSPROT databank search. Thus, the isolated protein is 
yet unidentified and might belong to a new subfamily of N- 
acetyltransferases. 
Acetylation of tryptamine may represent the involvement of
aaNAT in neurotransmitter inactivation. In addition, amine 
acetylation plays a role in melatonin synthesis with serotonin 
as substrate and the hardening of the insect cuticle involves the 
acetylation of dopamine. We, therefore, were interested in the 
affinities of aaNAT for the three different substrates. Km values 
for tryptamine, serotonin and dopamine were determined in the 
pool of active fractions after Hydroxylapatite chromatography. 
As shown in Table 3, aaNAT acetylates all tested amines with 
the same affinity, indicating that the purified enzyme might be 
involved in all three acetylation functions. 
If light-regulated melatonin formation is indeed a general 
process in all animals, an important question isif the character- 
istics of the Drosophila aaNAT protein are comparable to the 
properties of the pineal aaNAT. A first criterion were our 
kinetic studies: the Km value of 0.89 mM for tryptamine acetyl- 
ation in Drosophila lies in the same order of magnitude as the 
Km of 0.16 mM found for tryptamine acetylation i the pineal 
gland of rabbits [24]. Further parallels were found in the behav- 
ior during purification: the isolated protein had a molecular 
mass of around 30 kDa. In forskolin/camptothecin-stimulated 
Y79 human retinoblastoma cells, a 30-kDa protein was recently 
identified by Janavs et al. [26], the radiolabeling of which was 
consistently increased with increases in aaNAT activity and 
Table 3 
Internal peptide sequences of aaNAT 
4aa 
5aa 
14aa 
20aa 
Tyr-Ser-Leu-Lys 
Thr-Phe-Phe-Phe-Lys 
Asp-Glu-Pro-Leu-Asn-Thr-Phe-Leu-Asp-Leu-Gly-Glu- 
Cys-Lys 
Val-Asp-Gln-Asp-Cys-Pro-Tyr-Thr-Ile-Glu-Leu-Ile-Gln- 
Pro-Glu-Asp-Gly-Gly/Glu-Ala-Val 
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melatonin concentration. I  addition, as in protocols for the 
isolation of pineal aaNAT, the presence of the reducing agent 
DTT was required in order to prevent loss of enzyme actvitiy. 
The last step in melatonin synthesis is the methylation of 
acetylserotonin by the enzyme hydroxyindole-O-methyltrans- 
ferase (HIOMT). Since human pineal HIOMT exhibits homol- 
ogy with a plant and four bacterial O-methyltransferases [27]
and antibodies raised against bovine pineal HIOMT cross-react 
with cockroach cells in the optic lobe [28], the melatonin synthe- 
sis pathway seems indeed highly conserved in evolution. The 
Drosophila aaNAT cDNA could, therefore, become an impor- 
tant tool for the isolation of the pineal aaNAT. The molecular 
cloning of this cDNA is our next goal. 
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